NCI Seeks Input for Support of Frederick National Laboratory for Cancer Research—Deadline for RFI Extended
NCI has issued a Request for Information (RFI) to aid in planning a re-competition for supporting the Frederick National Laboratory for Cancer Research (FNLCR).
As a Federally Funded Research and Development Center (FFRDC), the Frederick National Lab provides rapid-response capabilities and one-of-a-kind resources for the biomedical research community (including informatics and data science expertise) on behalf of NCI and other NIH Institutes and Federal agencies.
The lab works at the forefront of basic, translational, and clinical science, with a focus on cancer, AIDS, and infectious disease through a collaborative effort between NCI and the Department of Energy. This program encompasses three major national initiatives; the Precision Medicine Initiative, the National Strategic Computing Initiative, and the Cancer Moonshot℠. FNLCR’s contributions include notable projects such as the Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium and the Cancer Distributed Learning Environment (CANDLE).
Respondents are urged to respond to this RFI by 4:00 p.m. ET on December 14, 2020. Entities eligible to operate, manage, or administer an FFRDC include:
- a single university or consortium of universities,
- other not-for-profit or nonprofit organizations,
- industrial firms serving as autonomous organizations (identified separately from any parent organization), or
- firms that represent industry/academia partnerships.